RA Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

RA Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-902,383	Closed	-$54M	–	52
2019 Q4	$54M	Buy	+902,383	New	+$33.9M	1.64%	17
2017 Q2	–	Sell	-532,426	Closed	-$9.07M	–	29
2017 Q1	$9.07M	Hold	532,426	–	–	1.11%	14
2016 Q4	$9.73M	Sell	532,426 -175,000	-25%	-$3.02M	1.38%	14
2016 Q3	$12.6M	Buy	+707,426	New	+$10.7M	1.3%	19

RA Capital Management's BOLD Position: Q1 2020 in Review

RA Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 902,383 shares — an estimated $54M sold.

RA Capital Management first reported a position in BOLD in Q3 2016 and held it in 4 quarters. The position peaked at $54M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

RA Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
RA Capital Management sold 902,383 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $54M.
RA Capital Management first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 4 quarters.
RA Capital Management's Audentes Therapeutics, Inc position peaked at $54M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on RA Capital Management's 13F filing for Q1 2020, filed 15 May 2020.